Drugs / Hydergotoxine mesylate
last change Mar 2018 re-read 3 minutes ago

Hydergotoxine mesylate

Developed for
cerebrovascular disorder

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT04958512 Comparator Aug 2017 → Jan 2018 cerebrovascular disorder Peking University Third Hospital Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hydergotoxine mesylate ClinicalTrials.gov intervention name — accepted as the source's own label NCT04958512 ↗